23. aprillil kell 15:30-17:00 toimub Tartu Biotehnoloogia Pargi I korruse seminariruumis ümarlaud USA biotehnoloogia ettevõtte MiroMatrix juhi Jeff Rossiga.
Tule ja saa osa koostöövõimaluste arutelust, Jeff Rossi tutvustustest USA biotehnoloogia turu trendidest ja välisfirmade võimalustest ja barjääridest USA turule sisenemiseks biotehnoloogia valdkonnas.
Dr. Ross brings more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices to Miromatrix including concept development, preclinical, clinical, manufacturing, and commercialization. He has held various technical and management positions at Guidant, Athersys and SurModics. Since coming to Miromatrix in 2010 he has been pivotal in the development, manufacturing and regulatory clearance of the innovative MIROMESH and MIRODERM product lines. He has spearheaded development, global patent strategy, and fundraising for the revolutionary whole organ transplant program and its key decellularization technology. Dr. Ross has over 30 patents along with scientific publications in Nature and other peer reviewed journals. He holds a Master’s degree in Biomedical Engineering and a Ph.D. in Molecular, Cellular and Developmental Biology from the University of Minnesota.